Log in to save to my catalogue

Molecular profile to guide personalized medicine in adult patients with primary brain tumors: result...

Molecular profile to guide personalized medicine in adult patients with primary brain tumors: result...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03915456v1

Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trial

About this item

Full title

Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trial

Publisher

New York: Springer US

Journal title

Medical oncology (Northwood, London, England), 2022-01, Vol.39 (1), p.4-4, Article 4

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Immunohistochemistry and recent molecular technologies progressively guided access to personalized anti-tumoral therapies. We explored the feasibility, efficacy, and the impact of molecular profiling in patients with advanced brain tumors. This multicentric prospective trial ProfiLER enrolled patients with primary brain tumors, who have been pre-tr...

Alternative Titles

Full title

Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_hal_03915456v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03915456v1

Other Identifiers

ISSN

1357-0560

E-ISSN

1559-131X

DOI

10.1007/s12032-021-01536-4

How to access this item